13F

Stock

Halozyme Therapeutics, Inc.

HALO · held by 4 managers

Reported value

$18.8M

Holders

4

+1 new · −0 exited

Holders’ est. mark

−$6.18M

Price effect on 3 books still in the name

Largest holder

$11.2M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC1.54M$11.2M−$6.02MAdded$3.75M
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main8.75M$7.29M−$131.3KCut−$131.3K
Henshaw Capital LLC9.51K$343K−$20.2KCut−$20.2K

Positions as of Q2 2023. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.